Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

This systematic review investigated buprenorphine doses and formulations on craving during the induction and maintenance phases of treatment, and for context also compared the craving response to o

Lit review | 2022
Substitution/OAT

This study aimed to evaluate the effectiveness of flexible take-home dosing of buprenorphine/naloxone (BUP/NX) and methadone standard model of care in reducing depressive symptoms in people with pr

Original research | 2022
Substitution/OAT, Mental health, About PWUD

This study draws on 20 months of ethnographic fieldwork in Vancouver, BC (July 2018 to March 2020), to explore how OPS responders who are PWUD developed and enacted expertise in overdose response.

Original research | 2023
About PWUD, SCS/OPS, Overdose
Guide or handbook | 2022
Policy/Regulatory, Clinical guidance

In WV, only 18% of providers including physicians, physician assistants, and nurse practitioners are waivered, and 44% of non-waivered providers were not interested in free training even if compens

Original research | 2022
Hesitancy of prescribers , About prescribers, Policy/Regulatory, Stigma, Barriers and enablers, Rural/remote

Our study objectives were to estimate the prevalence of and identify factors associated with inability to contact OAT prescribers when in need among people on OAT in a Canadian setting during the d

Original research | 2022
About prescribers, About PWUD, Barriers and enablers

This paper seeks to understand how trust in service providers fosters (or inhibits) effective service engagement from the perspective of people who inject drugs during the prison post-release perio

Original research | 2023
About PWUD, Barriers and enablers, Legal system/law enforcement
Video | 2022
Indigenous, Harm reduction
Rapport | 2022
la réduction des méfaits, les obstacles et les facilitateurs, le régime juridique / l'application de la loi
Report | 2022
Harm reduction, Barriers and enablers, Legal system/law enforcement
Webpage | 2022
Illegal drugs, Drug checking

Since the discovery of its anti-addictive properties by Howard S. Lotsof in 1962, ibogaine has been used experimentally to treat substance use disorders (SUD), especially those involving opioids.

Original research | 2022
About PWUD, Hallucinogens/psychedelics, Illegal drugs

Fentanyl is a highly lipophilic mu opioid receptor agonist increasingly found in heroin and other drug supplies that is contributing to marked increases in opioid-related overdose and may be compli

Original research | 2022
About PWUD, Withdrawal, Drug checking, Transitions in care/treatment

To assess the risk of opioid-related adverse events following opioid initiation among adults with versus without intellectual and developmental disability (IDD).

Original research | 2022
Chronic pain, Mental health

In 2000, the Portuguese minority socialist government decriminalised the possession and consumption of drugs.

Commentary | 2022
Decriminalization/legalization, Policy/Regulatory, Advocacy

Among veterans in care reporting opioid use, we investigated the association between ceasing opioid use on subsequent reduction in report of other substance use and improvements in pain, anxiety, a

Original research | 2023
About PWUD, Chronic pain, Mental health, Outcomes

The purpose of this literature review is to identify and summarize the evidence base on the associations between parental incarceration (PI) and subsequent drug use in the United States.

Lit review | 2022
Legal system/law enforcement, About PWUD

The potential misapplication of current opioid prescribing policies remains understudied and may have substantial adverse implications for patient safety.

Original research | 2023
About prescribers, Policy/Regulatory, Chronic pain

Refine Your Search

Keywords
Format
Region